Special Issue "Current Concept and Emerging Treatments in Autoimmune Bullous Skin Disorders"
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 2506
Interests: autoimmune bullous diseases; lupus; dermatomyositis; cutaneous lymphomas; psoriasis; atopic dermatitis
Autoimmune bullous diseases are typical examples of autoantibody-mediated, organ-specific autoimmune disorders. Although there are still gaps in the precise description of their pathogenetic mechanisms, we know that the key step is the formation of circulating and tissue-bound autoantibodies against target adhesion structures of the skin and mucous membranes.
This spectrum of diseases was included in the spectrum of orphan diseases for decades. After the introduction of systemic steroids, most of the available immunomodulatory additive medications were not able to achieve a significant and durable therapeutic response.
Rituximab was a huge step in the treatment of pemphigus, and many more targeted therapies have been investigated in pemphigus, bullous pemphigoid and other less frequent autoimmune bullous diseases.
In this issue, we expect to present information on the emerging therapies in this extremely interesting field of dermatology.
Prof. Dr. Aikaterini Patsatsi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Pemphigus vulgaris
- Pemphigus foliaceus
- Bullous pemphigoid
- Epidermolysis bullosa acquisita
- Mucous membrane pemphigoid
- Dermatitis herpetiformis